| | 51762-05-1 Basic information More.. |
| Product Name: | Cefroxadine | | Synonyms: | cxd;CEFROXADINE;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[(amino-1,4-cyclohexadien-1-ylacetyl)amino]-3-methoxy-8-oxo-, [6R-[6α,7β(R*)]]-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-amino-1,4-cyclohexadien-1-ylacetyl]amino]-3-methoxy-8-oxo-, (6R,7R)-;Oraspor;(6R,7R)-7-[[(2R)-2-Amino-2-(1-cyclohexa-1,4-dienyl)acetyl]amino]-3-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;(6R,7R)-7-[[(R)-Amino(1,4-cyclohexadien-1-yl)acetyl]amino]-3-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;C12979 | | CAS: | 51762-05-1 | | MF: | C16H19N3O5S | | MW: | 365.4 | | EINECS: | 257-391-8 | | Mol File: | 51762-05-1.mol |  |
Use
Cefroxadine is closely related to cefradine, the structure differing
only by the presence of a methoxy group replacing methyl at the C-3 position. The antimicrobial spectrum is identical
to that of cefradine and cefalexin. A dose of
1 g as film-coated tablets produced mean peak plasma levels
of 25 mg/L at 1 h. Absorption is depressed and delayed by
administration with food. The plasma elimination half-life is
0.8 h, rising to 40 h in end-stage renal failure and falling to
3.4 h during hemodialysis. Around 85% of an oral dose is
excreted unchanged in the urine. It is available in Japan.
- Cefroxadine
-
- US $0.00-0.00 / Kg
- 2020-05-26
- CAS:51762-05-1
- Min. Order: 1KG
- Purity: 99.0%
- Supply Ability: 500 MT
- Cefroxadine
-
- US $7.00 / kg
- 2019-07-06
- CAS: 51762-05-1
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 100kg
|
|
51762-05-1
Recommend Suppliers |
|